A pilot study of active immunotherapy with CEA (6D) VRP vaccine (AVX701) in patients with stage III colon cancer.

Clinical Trial Grant

Duke Scholars

Principal Investigator Michael Aaron Morse Medicine, Medical Oncology

Awarded By

AlphaVax, Inc.

Start Date

October 1, 2013

End Date

September 1, 2021

Awarded By

AlphaVax, Inc.

Start Date

October 1, 2013

End Date

September 1, 2021